Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity ...
The action of the peptide hormone adrenocorticotropin (ACTH) to stimulate glucocorticoid production by the adrenal gland is an essential physiologic process, yet is dependent on a single unique ...
First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfuncti ...
Experts highlight how adrenal disorders such as Conn’s syndrome and Cushing’s syndrome can silently damage the kidneys. Primary hyperaldosteronism occurs when an adrenal tumor produces excess ...
Experts highlight how adrenal disorders such as Conn’s syndrome and Cushing’s syndrome can silently damage the kidneys.
(MENAFN- EIN Presswire) EINPresswire/ -- During National Kidney Month, the Carling Adrenal Center is urging patients and physicians to recognize a frequently missed cause of kidney damage: ...
TAMPA, FL, UNITED STATES, March 6, 2026 /EINPresswire.com/ — During National Kidney Month, the Carling Adrenal Center is urging patients and physicians to recognize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results